Why the study?
What are the determinants of coronary sinus noradrenaline and adrenaline concentrations in patients with ischaemic heart disease before and after intravenous propranolol?
What are the determinants of coronary sinus noradrenaline and adrenaline concentrations in patients with ischaemic heart disease before and after intravenous propranolol?
In patients with ischemic heart disease, arterial and coronary sinus noradrenaline levels are closely correlated and are related to left ventricular end-diastolic pressure and pulmonary artery oxygen saturation.
Answers are grounded in this paper and cite their sources.
Arterial NA may surrogate coronary sinus sampling in IHD; leaves open whether LVEDP association informs therapy.
Arterial and coronary sinus noradrenaline (NA) and adrenaline (A) concentrations, cardiac output, pulmonary artery oxygen saturation (PAO2), coronary sinus oxygen saturation, left ventricular end-diastolic pressure (LVEDP), and arterial pressure were examined in 21 patients with ischaemic heart disease at rest and during exercise before and after intravenous propranolol. The heart had a net uptake of A and a net release of NA. It can be estimated that at least 50% of NA in the coronary sinus derived from the heart. NA in the coronary sinus and in the arterial blood originated therefore, at least partially, in different tissues. The NA concentration showed close correlation with PAO2, but not with cardiac index or arterial blood pressure. Multiple regression analysis also revealed a relationship between LVEDP and arterial and coronary sinus NA independent of PAO2. A very close correlation between arterial and coronary sinus NA (r = 0.93, P less than 0.001) indicates that they are largely controlled by the same factors.
No takes yet. Share an insight, caveat, or question.
Hansen et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: